Phase 2 trial of the topoisomerase II inhibitor, amrubicin, as second-line therapy in patients with metastatic urothelial carcinoma
Titel:
Phase 2 trial of the topoisomerase II inhibitor, amrubicin, as second-line therapy in patients with metastatic urothelial carcinoma
Auteur:
Galsky, Matthew D. Hahn, Noah M. Wong, Bryan Lee, Karen M. Argiriadi, Pamela Albany, Costantine Gimpel-Tetra, Kiev Lowe, Nancy Shahin, Mohamed Patel, Vaibhav Tsao, Che-Kai Oh, William K.